Focused on Every Breath
Diagnose Asthma with Confidence
Methapharm Respiratory’s ambition is to ensure people with asthma symptoms have the right diagnosis.
Methapharm Respiratory is part of Methapharm Specialty Pharmaceuticals.
Asthma is one of the most prevalent chronic respiratory conditions globally. Ensuring that patients have the right diagnosis is the first step in improving the lives of millions of people who struggle with the disease. We provide clinicians with the diagnostic tools to accurately assess people experiencing symptoms like cough, wheeze and shortness of breath. Our globally trusted diagnostic products are recommended in the ERS/ATS guidelines as well as other international practice guidelines.
Bronchial challenge tests with Provocholine (methacholine) and Aridol (mannitol) are objective and evidence-based measures of airway hyperresponsiveness, a key feature of asthma, and are part of the diagnostic work-up for patients suspected of having asthma. The right diagnosis is key.
As a committed partner, we also offer training and education (CSRT CE/CPD credits) at no cost to support healthcare providers as they help patients along their diagnostic journey.
Consider the consequences of an incorrect diagnosis of asthma:
Ineffective treatments
Inappropriate medications
Poor quality of life
Impact on work and school performance
Consider the consequences of an incorrect diagnosis of asthma:
Ineffective treatments
Inappropriate medications
Poor quality of life
Impact on work and school performance
Blog
Career Transitions – From Clinic to Industry
Holy Wilson, RPFT
When I was asked if I would like to write for this blog I had just moved from the U.S. to southern Portugal. It was the perfect time to put my journey into words of how I transitioned from working as a Pulmonary Function Technologist in hospitals to working remotely on the industry side of respiratory diagnostics from my home in Portugal. This is my story.
Asthma is (not) just asthma
Isn’t it just asthma? Actually, no. Over the years, the definition of asthma has changed. Rather than a catch-all diagnosis for bronchoconstriction, airway inflammation, wheezing, cough and mucus production, asthma is recognized as an umbrella term with multiple presentations of the physical symptoms we know as asthma.